Vitamin and dietary supplement market to reach $299.16 billion by 2030 at 10.0% CAGR, driven by growing emphasis on preventive healthcare.
Read More
Vitamin a supplements market to reach $10.27 billion by 2030 at 9.3% CAGR, driven by rising health and wellness consciousness.
Read More
Viscosupplementation market to reach $7.34 billion by 2030 at 10.2% CAGR, driven by rising prevalence of osteoarthritis globally.
Read More
Viral vectors and plasmid dna market to reach $1.89 billion by 2030 at 6.6% CAGR, driven by increasing incidence of tuberculosis cases.
Read More
Viral vector production research use market to reach $3.56 billion by 2030 at 14.9% CAGR, driven by rising occurrence of genetic disorders.
Read More
Viral vector manufacturing market to reach $21.31 billion by 2030 at 21.1% CAGR, driven by increasing prevalence of cancer and infectious diseases.
Read More
Viral vector contract development and manufacturing organization market to reach $3.01 billion by 2030 at 15.3% CAGR, driven by growing investment in gene therapy research.
Read More
Viral clearance market to reach $2.06 billion by 2030 at 16.4% CAGR, driven by rising prevalence of chronic diseases and biologics production.
Read More
Vinpocetine market to reach $20.94 billion by 2030 at 9.4% CAGR, driven by increased demand for nutraceuticals supporting brain health.
Read More
Vinca alkaloid active pharmaceutical ingredient market to reach $1.88 billion by 2030 at 7.0% CAGR, driven by rising incidence of cancer worldwide.
Read More